Literature DB >> 20975580

Cow's-milk allergy is a risk factor for the development of FGIDs in children.

Miguel Saps1, Peter Lu, Silvana Bonilla.   

Abstract

OBJECTIVES: Functional gastrointestinal disorders (FGIDs) are common in children. Their pathogenesis remains unknown and is most likely multifactorial. We hypothesized that noninfectious causes of inflammation affecting the gastrointestinal (GI) tract early in life, such as cow's-milk allergy (CMA), can predispose to the development of FGIDs later in childhood. PATIENTS AND METHODS: Case-control study. Subjects were patients between 4 and 18 years diagnosed with CMA in the first year of life at Children's Memorial Hospital in Chicago, IL, between January 2000 and June 2009. Diagnosis of CMA was based on history and clinical findings. Siblings 4 to 18 years of age without a history of CMA were selected as controls. Cases completed the parental form of the Pediatric Gastrointestinal Symptoms Rome III version questionnaire to assess for GI symptoms.
RESULTS: Fifty-two subjects (mean age 8.1 ± 4.48 years, 62% girls) and 53 controls (mean age 9.7 ± 4.20 years, 55% girls) participated in the study. Twenty-three of 52 subjects (44.2%) reported GI symptoms that included abdominal pain, constipation, or diarrhea compared with 11 of 53 controls (20.75%) (odds ratio 3.03, P = 0.01). Abdominal pain was significantly more common in cases (16/52, 30.8%) versus controls (5/53, 9.43%) (odds ratio 4.27 [1.43-12.7]) (χ² = 7.47, P = 0.01). Abnormal stool habits were more common in cases (15/52, 28.8%) versus controls (7/53, 13.2%), but the difference was not statistically significant. Ten of 52 subjects (19.2%) met the Questionnaire on Pediatric Gastrointestinal Symptoms Rome III version criteria for diagnosis of an FGID (7 irritable bowel syndrome, 2 functional dyspepsia, 1 functional abdominal pain), whereas none in the control group did.
CONCLUSIONS: CMA constitutes a risk factor for the development of FGIDs in children.

Entities:  

Mesh:

Year:  2011        PMID: 20975580     DOI: 10.1097/MPG.0b013e3181e85b55

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  24 in total

Review 1.  Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman; Jennifer M Colombo; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 2.  Functional abdominal pain in childhood: background studies and recent research trends.

Authors:  Rona L Levy; Miranda A L van Tilburg
Journal:  Pain Res Manag       Date:  2012 Nov-Dec       Impact factor: 3.037

Review 3.  The use of non-narcotic pain medication in pediatric gastroenterology.

Authors:  Adrian Miranda; Miguel Saps
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

4.  Developmental origins of functional dyspepsia-like gastric hypersensitivity in rats.

Authors:  John H Winston; Sushil K Sarna
Journal:  Gastroenterology       Date:  2012-11-08       Impact factor: 22.682

5.  Enhanced sympathetic nerve activity induced by neonatal colon inflammation induces gastric hypersensitivity and anxiety-like behavior in adult rats.

Authors:  John H Winston; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-05       Impact factor: 4.052

6.  Developmental origins of colon smooth muscle dysfunction in IBS-like rats.

Authors:  Qingjie Li; John H Winston; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

7.  Functional gastrointestinal disorders: Link discovered between cow's-milk allergy and functional gastrointestinal disorders in children.

Authors:  Rachel Thompson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

8.  Immune Activation in Functional Gastrointestinal Disorders.

Authors:  Grace Burns; Jennifer Pryor; Gerald Holtmann; Marjorie M Walker; Nicholas J Talley; Simon Keely
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-10

Review 9.  Brain-gut axis: from basic understanding to treatment of IBS and related disorders.

Authors:  Michael Camilleri; Carlo Di Lorenzo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-04       Impact factor: 2.839

10.  Noninflammatory upregulation of nerve growth factor underlies gastric hypersensitivity induced by neonatal colon inflammation.

Authors:  Qingjie Li; John H Winston; Sushil K Sarna
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-25       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.